tiprankstipranks
Sutro announces data from Phase 1b study of Luvelta in combo with Bevacizumab
PremiumThe FlySutro announces data from Phase 1b study of Luvelta in combo with Bevacizumab
3M ago
Sutro Biopharma announces initiation of REFRalphaME-L1 Phase 2 trial
Premium
The Fly
Sutro Biopharma announces initiation of REFRalphaME-L1 Phase 2 trial
4M ago
Sutro Biopharma price target lowered to $15 from $18 at Truist
Premium
The Fly
Sutro Biopharma price target lowered to $15 from $18 at Truist
4M ago
Coping with a Wild Ride: Investing in Sutro Biopharma (NASDAQ:STRO)
PremiumMarket NewsCoping with a Wild Ride: Investing in Sutro Biopharma (NASDAQ:STRO)
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
Sutro initiated with Buy on ovarian cancer potential at BofA
PremiumThe FlySutro initiated with Buy on ovarian cancer potential at BofA
8M ago
Sutro Biopharma initiated with a Buy at BofA
Premium
The Fly
Sutro Biopharma initiated with a Buy at BofA
8M ago
Sutro announces initiation of randomized portion of REFRalphaME-O1 trial
Premium
The Fly
Sutro announces initiation of randomized portion of REFRalphaME-O1 trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100